| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase binding | DOCK1 EPRS1 FLNA RAPGEF6 FGD2 SPTBN1 RABGAP1 SH3BP4 RASIP1 EHD1 CLTA RABGEF1 | 2.08e-05 | 360 | 152 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | actin filament binding | 6.22e-05 | 227 | 152 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNA SPAST TRAF3IP1 MYO7B SYNE1 SPTA1 SPTAN1 SPTBN1 SPTBN2 TOGARAM1 RABGAP1 VPS16 KIF20B S100A8 SIRT2 TTBK1 DLC1 MARK4 MACF1 RP1 JAKMIP1 | 9.15e-05 | 1099 | 152 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 SPAST MYO7B DYNC2H1 SAE1 NLRP1 CHD7 KIF20B ZRANB3 MDN1 MACF1 CHD6 DNAH5 DNAH8 | 2.57e-04 | 614 | 152 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | cadherin binding | 2.78e-04 | 339 | 152 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.24e-04 | 18 | 152 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | tubulin binding | SPAST TRAF3IP1 TOGARAM1 RABGAP1 KIF20B S100A8 SIRT2 MARK4 MACF1 RP1 JAKMIP1 | 4.47e-04 | 428 | 152 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D19 DOCK1 RAPGEF6 FGD2 PLEKHG7 PSD3 TBC1D22B RABGAP1 SH3BP4 DLC1 RABGEF1 DNMBP | 5.15e-04 | 507 | 152 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D19 DOCK1 RAPGEF6 FGD2 PLEKHG7 PSD3 TBC1D22B RABGAP1 SH3BP4 DLC1 RABGEF1 DNMBP | 5.15e-04 | 507 | 152 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA3 SPAST DYNC2H1 NLRP1 CHD7 KIF20B MDN1 MACF1 CHD6 DNAH5 DNAH8 | 5.73e-04 | 441 | 152 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | microtubule binding | SPAST TRAF3IP1 TOGARAM1 KIF20B S100A8 MARK4 MACF1 RP1 JAKMIP1 | 6.01e-04 | 308 | 152 | 9 | GO:0008017 |
| GeneOntologyMolecularFunction | small GTPase binding | 8.06e-04 | 321 | 152 | 9 | GO:0031267 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | TBC1D19 FLNA RAPGEF6 STON1 TRAF3IP1 FGD2 DYNC2H1 PODXL SYNE1 DZIP1L TOGARAM1 TBC1D22B RABGAP1 PDCL2 CFAP298 EHD1 MARK4 TEKT1 PRKCQ RP1 MPHOSPH9 CFAP44 DNMBP DNAH5 DNAH8 | 2.31e-11 | 670 | 152 | 25 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | TBC1D19 FLNA RAPGEF6 STON1 TRAF3IP1 FGD2 DYNC2H1 PODXL SYNE1 DZIP1L TOGARAM1 TBC1D22B RABGAP1 PDCL2 CFAP298 EHD1 MARK4 TEKT1 PRKCQ RP1 MPHOSPH9 CFAP44 DNMBP DNAH5 DNAH8 | 3.70e-11 | 685 | 152 | 25 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | TBC1D19 FLNA TRAF3IP1 DYNC2H1 SYNE1 DZIP1L TOGARAM1 TBC1D22B RABGAP1 PDCL2 CFAP298 EHD1 MARK4 TEKT1 RP1 MPHOSPH9 CFAP44 DNMBP DNAH5 DNAH8 | 1.06e-10 | 444 | 152 | 20 | GO:0060271 |
| GeneOntologyBiologicalProcess | cilium organization | TBC1D19 FLNA TRAF3IP1 DYNC2H1 SYNE1 DZIP1L TOGARAM1 TBC1D22B RABGAP1 PDCL2 CFAP298 EHD1 MARK4 TEKT1 RP1 MPHOSPH9 CFAP44 DNMBP DNAH5 DNAH8 | 3.59e-10 | 476 | 152 | 20 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | TBC1D19 DOCK1 FLNA ABCA3 TRAF3IP1 PODXL SYNE1 SPTA1 SPTAN1 SPTBN1 SPTBN2 TOGARAM1 PPHLN1 TBC1D22B RABGAP1 VPS16 DNAJC6 RASIP1 SIRT2 TTBK1 DLC1 RACK1 MARK4 CHEK2 MACF1 PRKCQ RP1 MPHOSPH9 | 4.16e-08 | 1189 | 152 | 28 | GO:0044087 |
| GeneOntologyBiologicalProcess | organelle assembly | TBC1D19 FLNA ABCA3 TRAF3IP1 DYNC2H1 SYNE1 DZIP1L SPTBN2 UBAP1 TOGARAM1 TBC1D22B RABGAP1 PDCL2 CFAP298 MDN1 EHD1 MARK4 CHEK2 TEKT1 RP1 MPHOSPH9 PRKDC CFAP44 DNMBP DNAH5 DNAH8 | 2.46e-07 | 1138 | 152 | 26 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TBC1D19 SMG1 FLNA SPAST TRAF3IP1 SYNE1 SPTA1 SPTAN1 SPTBN1 SPTBN2 TOGARAM1 PPHLN1 TBC1D22B MACROH2A1 RABGAP1 KIF20B S100A8 SIRT2 BNIP3L DLC1 CDC16 MARK4 CHEK2 PRKCQ RP1 MPHOSPH9 | 5.31e-06 | 1342 | 152 | 26 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 1.54e-05 | 108 | 152 | 7 | GO:1902017 | |
| GeneOntologyBiologicalProcess | nucleolus organization | 1.54e-05 | 21 | 152 | 4 | GO:0007000 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | ABCA3 TRAF3IP1 SPTA1 SPTAN1 SPTBN1 SPTBN2 TOGARAM1 VPS16 DNAJC6 RASIP1 SIRT2 TTBK1 RACK1 MARK4 | 1.62e-05 | 489 | 152 | 14 | GO:0043254 |
| GeneOntologyBiologicalProcess | rDNA heterochromatin formation | 4.53e-05 | 10 | 152 | 3 | GO:0000183 | |
| GeneOntologyBiologicalProcess | nucleolar chromatin organization | 6.20e-05 | 11 | 152 | 3 | GO:1990700 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | TBC1D19 PODXL SYNE1 TBC1D22B RABGAP1 MARK4 PRKCQ RP1 MPHOSPH9 | 9.58e-05 | 248 | 152 | 9 | GO:0120032 |
| GeneOntologyBiologicalProcess | protein depolymerization | 9.72e-05 | 144 | 152 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 1.02e-04 | 145 | 152 | 7 | GO:0001578 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | TBC1D19 PODXL SYNE1 TBC1D22B RABGAP1 MARK4 PRKCQ RP1 MPHOSPH9 | 1.05e-04 | 251 | 152 | 9 | GO:0060491 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.28e-04 | 105 | 152 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.33e-04 | 259 | 152 | 9 | GO:0051651 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.57e-04 | 109 | 152 | 6 | GO:0035082 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | HK2 SPAST STON1 SPTA1 SPTAN1 SPTBN1 SPTBN2 VPS16 DNAJC6 BNIP3L RACK1 LTN1 RP1 GCN1 | 1.95e-04 | 617 | 152 | 14 | GO:0022411 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | TBC1D19 SYNE1 SPTBN2 TBC1D22B RABGAP1 MARK4 CHEK2 RP1 MPHOSPH9 | 2.38e-04 | 280 | 152 | 9 | GO:1902115 |
| GeneOntologyBiologicalProcess | mitotic interphase | 3.21e-04 | 4 | 152 | 2 | GO:0051329 | |
| GeneOntologyBiologicalProcess | actin filament capping | 3.64e-04 | 46 | 152 | 4 | GO:0051693 | |
| GeneOntologyCellularComponent | spectrin | 3.12e-07 | 9 | 150 | 4 | GO:0008091 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.95e-05 | 9 | 150 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | paranodal junction | 5.73e-05 | 11 | 150 | 3 | GO:0033010 | |
| GeneOntologyCellularComponent | cuticular plate | 9.83e-05 | 13 | 150 | 3 | GO:0032437 | |
| GeneOntologyCellularComponent | axoneme | 1.28e-04 | 207 | 150 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.32e-04 | 208 | 150 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.65e-04 | 161 | 150 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | cytoplasmic region | SPAST TRAF3IP1 DYNC2H1 DZIP1L TOGARAM1 CLTA TEKT1 RP1 DNAH5 DNAH8 | 2.81e-04 | 360 | 150 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | chromosome, telomeric region | 2.85e-04 | 176 | 150 | 7 | GO:0000781 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 3.40e-04 | 129 | 150 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | SPAST TRAF3IP1 DYNC2H1 DZIP1L TOGARAM1 TEKT1 RP1 DNAH5 DNAH8 | 4.85e-04 | 317 | 150 | 9 | GO:0032838 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 5.57e-04 | 93 | 150 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | supramolecular fiber | FLNA SPAST DYNC2H1 SYNE1 SPTAN1 SPTBN1 DNAJB4 TOGARAM1 VPS16 KIF20B SIRT2 DLC1 TEKT1 MACF1 RP1 JAKMIP1 NME2 DNAH5 DNAH8 | 7.97e-04 | 1179 | 150 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | heterochromatin | 8.11e-04 | 101 | 150 | 5 | GO:0000792 | |
| GeneOntologyCellularComponent | supramolecular polymer | FLNA SPAST DYNC2H1 SYNE1 SPTAN1 SPTBN1 DNAJB4 TOGARAM1 VPS16 KIF20B SIRT2 DLC1 TEKT1 MACF1 RP1 JAKMIP1 NME2 DNAH5 DNAH8 | 8.64e-04 | 1187 | 150 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | chromosomal region | SP100 CBX3 MACROH2A1 SYCP2 SIRT2 CBX5 CFDP1 CHEK2 PDS5A PRKDC | 9.45e-04 | 421 | 150 | 10 | GO:0098687 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP6 FLNA SPAST SYNE1 ANXA4 SPTBN2 TRIM68 KIF20B RASIP1 SIRT2 TTBK1 RACK1 OSBPL3 EHD1 MANF NME2 | 1.12e-03 | 934 | 150 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | pericentric heterochromatin | 1.54e-03 | 32 | 150 | 3 | GO:0005721 | |
| GeneOntologyCellularComponent | microtubule | SPAST DYNC2H1 TOGARAM1 KIF20B SIRT2 TEKT1 MACF1 RP1 JAKMIP1 DNAH5 DNAH8 | 1.64e-03 | 533 | 150 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | FLNA SPAST DYNC2H1 TOGARAM1 VPS16 KIF20B SIRT2 DLC1 TEKT1 MACF1 RP1 JAKMIP1 NME2 DNAH5 DNAH8 | 2.07e-03 | 899 | 150 | 15 | GO:0099513 |
| Domain | SPEC | 6.40e-09 | 32 | 154 | 7 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 6.40e-09 | 32 | 154 | 7 | IPR018159 | |
| Domain | Spectrin | 2.56e-08 | 23 | 154 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 1.16e-07 | 29 | 154 | 6 | IPR002017 | |
| Domain | ACTININ_2 | 1.07e-06 | 23 | 154 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.07e-06 | 23 | 154 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.07e-06 | 23 | 154 | 5 | IPR001589 | |
| Domain | ATPase_dyneun-rel_AAA | 4.17e-06 | 14 | 154 | 4 | IPR011704 | |
| Domain | AAA_5 | 4.17e-06 | 14 | 154 | 4 | PF07728 | |
| Domain | DHC_N1 | 2.99e-05 | 8 | 154 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.99e-05 | 8 | 154 | 3 | IPR013594 | |
| Domain | Chromo_domain | 4.15e-05 | 24 | 154 | 4 | IPR023780 | |
| Domain | PH_dom-spectrin-type | 4.45e-05 | 9 | 154 | 3 | IPR001605 | |
| Domain | Chromo | 5.77e-05 | 26 | 154 | 4 | PF00385 | |
| Domain | CHROMO_1 | 7.80e-05 | 28 | 154 | 4 | PS00598 | |
| Domain | CHROMO_2 | 7.80e-05 | 28 | 154 | 4 | PS50013 | |
| Domain | Chromodomain-like | 1.34e-04 | 32 | 154 | 4 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.51e-04 | 33 | 154 | 4 | IPR000953 | |
| Domain | CHROMO | 1.51e-04 | 33 | 154 | 4 | SM00298 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.87e-04 | 14 | 154 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.87e-04 | 14 | 154 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.87e-04 | 14 | 154 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.87e-04 | 14 | 154 | 3 | PF08393 | |
| Domain | MT | 1.87e-04 | 14 | 154 | 3 | PF12777 | |
| Domain | AAA_8 | 1.87e-04 | 14 | 154 | 3 | PF12780 | |
| Domain | CH | 1.98e-04 | 65 | 154 | 5 | SM00033 | |
| Domain | ChSh | 2.02e-04 | 3 | 154 | 2 | SM00300 | |
| Domain | Chromo_shadow_dom | 2.02e-04 | 3 | 154 | 2 | IPR008251 | |
| Domain | Chromo_shadow | 2.02e-04 | 3 | 154 | 2 | PF01393 | |
| Domain | DHC_fam | 2.33e-04 | 15 | 154 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.33e-04 | 15 | 154 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.33e-04 | 15 | 154 | 3 | IPR004273 | |
| Domain | CH | 2.81e-04 | 70 | 154 | 5 | PF00307 | |
| Domain | HEAT_REPEAT | 2.81e-04 | 70 | 154 | 5 | PS50077 | |
| Domain | - | 3.00e-04 | 71 | 154 | 5 | 1.10.418.10 | |
| Domain | CH | 3.42e-04 | 73 | 154 | 5 | PS50021 | |
| Domain | CH-domain | 3.87e-04 | 75 | 154 | 5 | IPR001715 | |
| Domain | Spectrin_bsu | 4.01e-04 | 4 | 154 | 2 | IPR016343 | |
| Domain | PI3_PI4_kinase | 4.10e-04 | 18 | 154 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 4.10e-04 | 18 | 154 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.10e-04 | 18 | 154 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 4.10e-04 | 18 | 154 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 4.10e-04 | 18 | 154 | 3 | PS50290 | |
| Domain | SH3 | 4.33e-04 | 216 | 154 | 8 | PS50002 | |
| Domain | SH3_domain | 4.89e-04 | 220 | 154 | 8 | IPR001452 | |
| Domain | UMA | 6.65e-04 | 5 | 154 | 2 | PS51497 | |
| Domain | UMA | 6.65e-04 | 5 | 154 | 2 | IPR023340 | |
| Domain | FATC | 6.65e-04 | 5 | 154 | 2 | PF02260 | |
| Domain | DAPIN | 7.55e-04 | 22 | 154 | 3 | PS50824 | |
| Domain | PYRIN | 7.55e-04 | 22 | 154 | 3 | SM01289 | |
| Domain | PYRIN | 7.55e-04 | 22 | 154 | 3 | PF02758 | |
| Domain | DAPIN | 7.55e-04 | 22 | 154 | 3 | IPR004020 | |
| Domain | NACHT | 8.63e-04 | 23 | 154 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 8.63e-04 | 23 | 154 | 3 | IPR007111 | |
| Domain | BRK | 9.91e-04 | 6 | 154 | 2 | SM00592 | |
| Domain | BRK_domain | 9.91e-04 | 6 | 154 | 2 | IPR006576 | |
| Domain | EFhand_Ca_insen | 9.91e-04 | 6 | 154 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 9.91e-04 | 6 | 154 | 2 | IPR014837 | |
| Domain | FAT | 9.91e-04 | 6 | 154 | 2 | PS51189 | |
| Domain | FATC | 9.91e-04 | 6 | 154 | 2 | PS51190 | |
| Domain | FATC_dom | 9.91e-04 | 6 | 154 | 2 | IPR003152 | |
| Domain | PIK_FAT | 9.91e-04 | 6 | 154 | 2 | IPR014009 | |
| Domain | BRK | 9.91e-04 | 6 | 154 | 2 | PF07533 | |
| Domain | FATC | 9.91e-04 | 6 | 154 | 2 | SM01343 | |
| Domain | AAA | 1.25e-03 | 144 | 154 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.25e-03 | 144 | 154 | 6 | IPR003593 | |
| Domain | - | ABCA3 SPAST MYO7B DYNC2H1 NLRP1 CHD7 ZRANB3 NLRP9 TRANK1 MDN1 EHD1 CHD6 DNAH5 DNAH8 NLRP8 | 1.30e-03 | 746 | 154 | 15 | 3.40.50.300 |
| Domain | P-loop_NTPase | ABCA3 SPAST MYO7B DYNC2H1 NLRP1 CHD7 KIF20B ZRANB3 NLRP9 TRANK1 MDN1 EHD1 CHD6 DNAH5 DNAH8 NLRP8 | 1.74e-03 | 848 | 154 | 16 | IPR027417 |
| Domain | SH3 | 2.12e-03 | 216 | 154 | 7 | SM00326 | |
| Domain | SNF2_N | 2.29e-03 | 32 | 154 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.29e-03 | 32 | 154 | 3 | PF00176 | |
| Domain | SH3_1 | 2.41e-03 | 164 | 154 | 6 | PF00018 | |
| Domain | IG_FLMN | 2.91e-03 | 10 | 154 | 2 | SM00557 | |
| Domain | Chromo_dom_subgr | 2.91e-03 | 10 | 154 | 2 | IPR017984 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.08e-06 | 10 | 122 | 4 | MM15112 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 FLNA HK2 RARS1 ACO2 PSMA3 SPTAN1 SPTBN1 NARS1 CBX3 SAE1 MACROH2A1 CHD7 VPS16 KIF20B MYEF2 WDR3 S100A8 USP14 ZC3H11A OXCT1 MDN1 RACK1 EHD1 LTN1 DLAT MACF1 PDS5A POLR1B ATIC PRKDC GCN1 PTCD3 | 1.16e-15 | 1353 | 155 | 33 | 29467282 |
| Pubmed | FLNA SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 BEND3 CHD7 PSMD12 MYEF2 WDR3 S100A8 ZC3H11A MDN1 RACK1 DLAT MACF1 PDS5A ATIC PRKDC GCN1 PTCD3 | 2.05e-13 | 653 | 155 | 22 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 FLNA HK2 RARS1 CACNA2D2 DYNC2H1 SYNE1 ACO2 PSMA3 SPTAN1 SPTBN1 CBX3 MACROH2A1 PSMD12 WDR3 S100A8 MRM3 ZC3H11A MDN1 RACK1 CDC16 CLTA DLAT PDS5A ATIC PRKDC DNAH5 GCN1 LRRFIP2 PTCD3 | 1.20e-12 | 1425 | 155 | 30 | 30948266 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 FLNA RARS1 DYNC2H1 SYNE1 ACO2 ANXA4 PSMA3 SPTA1 SPTAN1 SPTBN1 CBX3 PSMD12 MYEF2 USP14 MDN1 RACK1 CBX5 MACF1 ATIC PRKDC GCN1 | 1.31e-11 | 807 | 155 | 22 | 30575818 |
| Pubmed | SMG1 EPRS1 FLNA SP100 FOXRED1 SYNE1 ACO2 SPTA1 SPTAN1 DZIP1L SPTBN1 SPTBN2 CCDC127 CBX3 BEND3 MACROH2A1 FER1L6 MDN1 CBX5 MANF DLAT MACF1 SPDEF CHD6 PRKDC JAKMIP1 NME2 DNAH8 | 4.95e-11 | 1442 | 155 | 28 | 35575683 | |
| Pubmed | EPRS1 FLNA RARS1 ANXA4 PSMA3 SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 SAE1 PPHLN1 MACROH2A1 CHD7 WDR3 S100A8 MRM3 RACK1 OSBPL3 CDC16 EHD1 CLTA DLAT SDF4 GCN1 LRRFIP2 PTCD3 | 8.42e-11 | 1371 | 155 | 27 | 36244648 | |
| Pubmed | PCYT1A ANXA4 PSMA3 NARS1 CBX3 SAE1 DNAJB4 PPHLN1 MACROH2A1 RABGAP1 WDR3 USP14 ZC3H11A MDN1 RACK1 CBX5 CDC16 CFDP1 PDS5A ATIC PRKDC QSER1 NNMT | 1.65e-10 | 1014 | 155 | 23 | 32416067 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 FLNA SP100 RARS1 PSMA3 SPTAN1 SPTBN1 SPTBN2 NARS1 SAE1 RABGAP1 PSMD12 VPS16 WDR3 MDN1 RACK1 CLTA MACF1 PRKDC NME2 PTCD3 | 2.25e-10 | 847 | 155 | 21 | 35235311 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 PCYT1A FLNA RARS1 PSMA3 SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 SAE1 DNAJB4 PSMD12 MDN1 RACK1 CLTA DLAT MACF1 PDS5A ATIC PRKDC NME2 GCN1 PTCD3 | 3.32e-10 | 1149 | 155 | 24 | 35446349 |
| Pubmed | AKAP6 EPRS1 PCYT1A FOXRED1 SPAST TRAF3IP1 SYNE1 PSMA3 SPTAN1 SPTBN1 SPTBN2 NARS1 TRIM68 CFAP298 TRIM59 WDR3 GM2A DLAT MACF1 LRPAP1 CHD6 ATIC PRKDC JAKMIP1 FUT8 | 5.91e-10 | 1285 | 155 | 25 | 35914814 | |
| Pubmed | DOCK1 FLNA SP100 SYNE1 SPTAN1 SPTBN1 SPTBN2 CBX3 SH3BP4 S100A8 MACF1 LRPAP1 CHD6 MPHOSPH9 PRKDC GCN1 | 6.65e-10 | 486 | 155 | 16 | 20936779 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 PCYT1A FLNA SP100 HK2 RARS1 PSMA3 SPTAN1 SPTBN1 NARS1 UBAP1 CBX3 SAE1 DNAJB4 RABGAP1 PSMD12 USP14 OXCT1 RACK1 EHD1 MACF1 RABGEF1 ATIC PRKDC DNMBP GCN1 | 1.54e-09 | 1455 | 155 | 26 | 22863883 |
| Pubmed | EPRS1 FLNA TUT4 HK2 SPAST RARS1 ACO2 SPTAN1 SPTBN1 PSD3 MACROH2A1 RABGAP1 PSMD12 MYEF2 OXCT1 RACK1 CDC16 CLTA DLAT MACF1 RABGEF1 GCN1 PTCD3 | 1.54e-09 | 1139 | 155 | 23 | 36417873 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 FLNA HK2 RARS1 SPTAN1 SPTBN1 NARS1 SAE1 ZC3H11A MDN1 PDS5A PRKDC GCN1 | 3.66e-09 | 332 | 155 | 13 | 32786267 |
| Pubmed | FLNA RARS1 PSMA3 SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 MACROH2A1 PSMD12 USP14 CBX5 PRKDC | 3.93e-09 | 334 | 155 | 13 | 30425250 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | FLNA SPTAN1 SPTBN1 CBX3 MACROH2A1 MDN1 RACK1 CBX5 POLR1B PRKDC GCN1 | 4.69e-09 | 219 | 155 | 11 | 31353912 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPRS1 RARS1 ERAP1 PSMA3 SPTAN1 SPTBN1 SAE1 PSMD12 S100A8 MDN1 OTULIN RACK1 EHD1 LTN1 PRKDC LRRFIP2 PTCD3 | 5.62e-09 | 647 | 155 | 17 | 26618866 |
| Pubmed | AKAP6 SMG1 ERAP1 SYNE1 PSD3 TOGARAM1 CHD7 PASK MACF1 CHD6 GCN1 | 6.22e-09 | 225 | 155 | 11 | 12168954 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | FLNA HK2 SPTAN1 SPTBN1 SH3BP4 OTULIN CLTA MACF1 SDF4 PRKDC GCN1 | 9.76e-09 | 235 | 155 | 11 | 28378594 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNA ERAP1 PODXL ANXA4 PSMA3 SPTBN1 CBX3 DNAJB4 MACROH2A1 RABGAP1 PSMD12 S100A8 USP14 ZC3H11A OXCT1 OTULIN RACK1 CLTA CFDP1 MANF ATIC PRKDC NNMT GCN1 | 9.93e-09 | 1367 | 155 | 24 | 32687490 |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.35e-08 | 18 | 155 | 5 | 12119179 | |
| Pubmed | EPRS1 FLNA HK2 RARS1 PSMA3 CBX3 SAE1 PSMD12 USP14 OXCT1 CBX5 POLR1B PRKDC GCN1 PTCD3 | 1.94e-08 | 534 | 155 | 15 | 35032548 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | EPRS1 FLNA SYNE1 ACO2 SPTAN1 NARS1 CBX3 PPHLN1 MACROH2A1 PSMD12 MYEF2 ZC3H11A RACK1 DLAT PRKDC GCN1 PTCD3 | 2.37e-08 | 714 | 155 | 17 | 28302793 |
| Pubmed | PI4K2B SMG1 FLNA HK2 PSMA3 SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 PSMD12 WDR3 USP14 OXCT1 MDN1 EHD1 CLTA LTN1 PDS5A SDF4 PRKDC GCN1 LRRFIP2 PTCD3 | 2.66e-08 | 1440 | 155 | 24 | 30833792 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPRS1 FLNA RARS1 SPTAN1 SPTBN1 SPTBN2 S100A8 RACK1 DLAT ATIC PRKDC NME2 GCN1 PTCD3 | 3.43e-08 | 477 | 155 | 14 | 31300519 |
| Pubmed | EPRS1 FLNA RARS1 ACO2 SPTAN1 SPTBN1 NARS1 CBX3 SAE1 PSMD12 SH3BP4 USP14 RACK1 CBX5 WDR87 CLTA DLAT ATIC PRKDC NME2 GCN1 LRRFIP2 | 4.02e-08 | 1247 | 155 | 22 | 27684187 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 6.27e-08 | 118 | 155 | 8 | 27377895 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDE3B RAPGEF6 SPAST SPTAN1 SPTBN1 PSD3 TBC1D22B TRIM68 SH3BP4 DLC1 MDN1 OSBPL3 MARK4 MACF1 RABGEF1 MPHOSPH9 DNMBP CCDC102A | 6.39e-08 | 861 | 155 | 18 | 36931259 |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 7.80e-08 | 10 | 155 | 4 | 22159418 | |
| Pubmed | A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. | 7.80e-08 | 10 | 155 | 4 | 18548008 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | RARS1 ACO2 ANXA4 SPTAN1 SPTBN1 NARS1 CBX3 MACROH2A1 PSMD12 S100A8 RACK1 ATIC NME2 GCN1 PTCD3 | 1.03e-07 | 607 | 155 | 15 | 39147351 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | NARS1 CBX3 SAE1 PSMD12 VPS16 OXCT1 RACK1 CBX5 LTN1 PDS5A POLR1B SDF4 PRKDC DNAH5 DNAH8 GCN1 | 1.18e-07 | 704 | 155 | 16 | 29955894 |
| Pubmed | EPRS1 FLNA RARS1 ACO2 SPTAN1 SPTBN1 NARS1 CBX3 MACROH2A1 PSMD12 RACK1 EHD1 MANF MACF1 PRKDC GCN1 | 1.35e-07 | 711 | 155 | 16 | 33022573 | |
| Pubmed | Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition. | 1.41e-07 | 182 | 155 | 9 | 36225252 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FLNA TUT4 SPAST RARS1 DYNC2H1 PODXL ANXA4 PSMA3 SPTBN1 NARS1 PSMD12 SH3BP4 S100A8 RACK1 EHD1 GM2A ATIC PWWP3B MVB12B | 1.51e-07 | 1016 | 155 | 19 | 19056867 |
| Pubmed | EPRS1 FLNA RAPGEF6 RARS1 SPTAN1 SPTBN2 BEND3 USP14 ZC3H11A RACK1 CDC16 PRKDC QSER1 GCN1 | 1.92e-07 | 549 | 155 | 14 | 38280479 | |
| Pubmed | EPRS1 FLNA RARS1 PSMA3 SPTAN1 SPTBN1 DNAJB4 PSMD12 WDR3 MDN1 RACK1 DLAT PDS5A PRKDC GCN1 | 1.95e-07 | 638 | 155 | 15 | 33239621 | |
| Pubmed | EPRS1 FLNA FOXRED1 RARS1 SPTAN1 SPTBN1 SPTBN2 PPHLN1 MRM3 ZC3H11A DLAT PRKDC JAKMIP1 PTCD3 | 2.00e-07 | 551 | 155 | 14 | 34728620 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDE3B FOXRED1 TUT4 HK2 SYNE1 ACO2 PSMA3 BEND3 MACROH2A1 RABGAP1 RBM20 WDR3 MRM3 SIRT2 BNIP3L OXCT1 MDN1 CBX5 OSBPL3 DLAT PRKCQ NME2 PTCD3 | 2.26e-07 | 1496 | 155 | 23 | 32877691 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | EPRS1 FLNA PSMA3 SPTAN1 SPTBN1 PASK ZC3H11A OXCT1 CLTA LTN1 SDF4 PRKDC GCN1 CCDC102A | 2.65e-07 | 564 | 155 | 14 | 21565611 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | HK2 ANXA4 NARS1 ACAD10 PSMD12 SH3BP4 WDR3 USP14 MDN1 DLAT PDS5A POLR1B | 2.69e-07 | 400 | 155 | 12 | 35013556 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNA RARS1 ANXA4 SPTAN1 SPTBN1 SPTBN2 TBC1D22B MACROH2A1 RACK1 EHD1 GM2A MACF1 ATIC GCN1 | 2.71e-07 | 565 | 155 | 14 | 25468996 |
| Pubmed | EPRS1 POGLUT3 RARS1 ACO2 ANXA4 SPTAN1 SPTBN1 S100A8 OXCT1 CBX5 GM2A DLAT LRPAP1 SDF4 ATIC DNAH8 GNPAT | 3.28e-07 | 859 | 155 | 17 | 31536960 | |
| Pubmed | AKAP6 DOCK1 FLNA PNLIPRP1 ERAP1 PODXL SPTAN1 SPTBN1 UBAP1 DNAJC6 ZNF25 WDR3 S100A8 FANCB DLC1 MDN1 CBX5 CD101 LRP6 HSD17B2 CCDC70 | 3.30e-07 | 1293 | 155 | 21 | 15342556 | |
| Pubmed | TRAF3IP1 SYNE1 SPTAN1 SPTBN1 SPTBN2 CBX3 MACROH2A1 CHD7 DNAJC6 MYEF2 MDN1 RACK1 OSBPL3 MACF1 RABGEF1 JAKMIP1 QSER1 LRRFIP2 | 3.32e-07 | 963 | 155 | 18 | 28671696 | |
| Pubmed | Chromatin components as part of a putative transcriptional repressing complex. | 3.46e-07 | 4 | 155 | 3 | 9636147 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 9636146 | ||
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 3.46e-07 | 4 | 155 | 3 | 3862089 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 21412925 | ||
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 3.46e-07 | 4 | 155 | 3 | 12820899 | |
| Pubmed | AKAP6 EPRS1 FLNA RAPGEF6 DZIP1L SPTBN1 ESRP1 CCDC127 CHD7 TRIM59 ZRANB3 ZC3H11A RACK1 CBX5 OSBPL3 LTN1 MACF1 SDF4 QSER1 | 4.05e-07 | 1084 | 155 | 19 | 11544199 | |
| Pubmed | SMG1 RARS1 ACO2 PSMA3 SPTAN1 SPTBN1 BEND3 CHD7 PSMD12 RBM20 S100A8 RACK1 CFDP1 LRP6 DLAT PDS5A CHD6 ELK3 QSER1 NME2 SMAD5 PTCD3 | 4.16e-07 | 1429 | 155 | 22 | 35140242 | |
| Pubmed | 4.40e-07 | 272 | 155 | 10 | 31010829 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 FLNA FOXRED1 RARS1 ACO2 NARS1 CBX3 SAE1 MACROH2A1 CHD7 PSMD12 WDR3 MDN1 RACK1 CBX5 POLR1B CHD6 PRKCQ PRKDC GCN1 PTCD3 | 4.51e-07 | 1318 | 155 | 21 | 30463901 |
| Pubmed | EPRS1 FLNA RARS1 SYNE1 ACO2 NARS1 SAE1 PSMD12 MYEF2 RACK1 CLTA DLAT ATIC PRKDC NME2 GCN1 | 6.80e-07 | 803 | 155 | 16 | 36517590 | |
| Pubmed | EPRS1 FLNA RARS1 ACO2 PSMA3 SPTBN1 NARS1 CBX3 MACROH2A1 MDN1 RACK1 CLTA MACF1 PRKDC GCN1 | 7.11e-07 | 707 | 155 | 15 | 19738201 | |
| Pubmed | DOCK1 EPRS1 SPTBN1 PSD3 NARS1 CBX3 PSMD12 RACK1 EHD1 LRP6 MACF1 PDS5A MPHOSPH9 PRKDC GCN1 | 7.23e-07 | 708 | 155 | 15 | 39231216 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 FLNA RARS1 SYNE1 SPTBN2 CBX3 MACROH2A1 MYEF2 WDR3 ZC3H11A MDN1 RACK1 CBX5 CLTA MACF1 ATIC PRKDC GCN1 | 8.04e-07 | 1024 | 155 | 18 | 24711643 |
| Pubmed | POGLUT3 PDE3B DYNC2H1 SYNE1 SPTAN1 SPTBN1 SPTBN2 PSD3 DNAJB4 MACROH2A1 DNAJC6 SH3BP4 WDR3 PASK MDN1 CBX5 CLTA DLAT MACF1 LRPAP1 SDF4 PTCD3 | 8.08e-07 | 1487 | 155 | 22 | 33957083 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 FLNA SP100 RARS1 SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 PPHLN1 MACROH2A1 KIF20B WDR3 ZC3H11A RACK1 CDC16 POLR1B PRKDC LRRFIP2 PTCD3 | 8.88e-07 | 1257 | 155 | 20 | 36526897 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.04e-06 | 231 | 155 | 9 | 36597993 | |
| Pubmed | POGLUT3 TUT4 UBAP1 PPHLN1 CHD7 PSMD12 USP14 MANF LRPAP1 POLR1B SDF4 CHD6 MPHOSPH9 ATIC QSER1 | 1.11e-06 | 733 | 155 | 15 | 34672954 | |
| Pubmed | PI4K2B EPRS1 FLNA PDE3B HK2 RARS1 ERAP1 PSMD12 MDN1 OSBPL3 EHD1 CLTA SDF4 MPHOSPH9 ATIC PRKDC FUT8 GCN1 GNPAT | 1.23e-06 | 1168 | 155 | 19 | 19946888 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 FLNA RARS1 SYNE1 ACO2 SPTAN1 SPTBN1 SPTBN2 MACROH2A1 WDR3 S100A8 RACK1 OSBPL3 CLTA POLR1B PRKDC LRRFIP2 | 1.29e-06 | 949 | 155 | 17 | 36574265 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | DYNC2H1 ACO2 ANXA4 ACAD10 PSMD12 VPS16 TRIM59 MYEF2 PASK BNIP3L MDN1 LTN1 MACF1 PDS5A SDF4 PRKDC FUT8 GNPAT | 1.33e-06 | 1061 | 155 | 18 | 33845483 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EPRS1 FLNA CBX3 BEND3 PPHLN1 MACROH2A1 CHD7 KIF20B WDR3 ZC3H11A RACK1 CBX5 MANF PDS5A PRKDC QSER1 NME2 | 1.38e-06 | 954 | 155 | 17 | 36373674 |
| Pubmed | FLNA TUT4 DYNC2H1 PODXL SYNE1 ANXA4 SPTAN1 SPTBN1 DNAJB4 PSMD12 S100A8 RACK1 CDC16 CHD6 LRRFIP2 | 1.57e-06 | 754 | 155 | 15 | 35906200 | |
| Pubmed | ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors. | 1.72e-06 | 6 | 155 | 3 | 37069398 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EPRS1 SPTAN1 SPTBN1 CBX3 MACROH2A1 CHD7 MDN1 CBX5 CDC16 PDS5A PRKDC | 1.73e-06 | 394 | 155 | 11 | 27248496 |
| Pubmed | EPRS1 RARS1 PSMA3 CBX3 PPHLN1 PSMD12 MDN1 CLTA PDS5A PRKDC GCN1 | 1.95e-06 | 399 | 155 | 11 | 37536630 | |
| Pubmed | 2.11e-06 | 187 | 155 | 8 | 26460568 | ||
| Pubmed | EPRS1 FLNA RARS1 PSMA3 SPTAN1 SPTBN1 S100A8 RACK1 DLAT MACF1 PRKDC GCN1 | 2.16e-06 | 488 | 155 | 12 | 31324722 | |
| Pubmed | EPRS1 FLNA SPAST RARS1 PSMA3 NARS1 SAE1 BEND3 CHD7 PSMD12 USP14 ZC3H11A CLTA PDS5A ATIC PRKDC QSER1 NME2 | 2.29e-06 | 1103 | 155 | 18 | 34189442 | |
| Pubmed | EPRS1 HK2 RARS1 ACO2 SPTBN1 NARS1 MACROH2A1 S100A8 MACF1 PRKDC | 2.32e-06 | 327 | 155 | 10 | 31409639 | |
| Pubmed | FLNA RAPGEF6 SPTBN1 USP37 SH3BP4 OSBPL3 RABGEF1 PRKDC JAKMIP1 | 2.36e-06 | 255 | 155 | 9 | 15324660 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | SMG1 BEND3 PPHLN1 CHD7 KIF20B WDR3 EHD1 DLAT QSER1 DNMBP PTCD3 | 2.54e-06 | 410 | 155 | 11 | 26949251 |
| Pubmed | SP100 TUT4 CBX3 BEND3 MACROH2A1 MYEF2 PASK RACK1 CBX5 OSBPL3 CDC16 MARK4 LTN1 DLAT TEKT1 MACF1 SDF4 PTCD3 | 2.70e-06 | 1116 | 155 | 18 | 31753913 | |
| Pubmed | FLNA RAPGEF6 CBX3 BEND3 CHD7 RABGAP1 RBM20 KIF20B CHD6 NME2 GCN1 | 3.05e-06 | 418 | 155 | 11 | 34709266 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | ABCA3 SYNE1 ACO2 SPTBN2 TMC6 CBX3 SAE1 ZNF25 CFAP298 SIRT2 BNIP3L MARK4 JAKMIP1 QSER1 | 3.19e-06 | 697 | 155 | 14 | 28298427 |
| Pubmed | RARS1 SYNE1 PPHLN1 CHD7 KIF20B MYEF2 WDR3 MRM3 ZC3H11A MDN1 RACK1 CDC16 LTN1 MACF1 PDS5A POLR1B CHD6 NME2 FUT8 DNMBP PTCD3 | 3.39e-06 | 1497 | 155 | 21 | 31527615 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RARS1 ACO2 PSMA3 NARS1 CBX3 MYEF2 S100A8 ZC3H11A RACK1 CBX5 CLTA MANF GCN1 LRRFIP2 | 3.41e-06 | 701 | 155 | 14 | 30196744 |
| Pubmed | 4.02e-06 | 204 | 155 | 8 | 25659154 | ||
| Pubmed | 4.60e-06 | 147 | 155 | 7 | 16959763 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 5.03e-06 | 357 | 155 | 10 | 37059091 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 5.19e-06 | 281 | 155 | 9 | 30455355 | |
| Pubmed | TBC1D19 EPRS1 FLNA SPAST SPTAN1 SPTBN1 MACF1 ATIC PRKDC PTCD3 | 5.42e-06 | 360 | 155 | 10 | 33111431 | |
| Pubmed | 5.50e-06 | 151 | 155 | 7 | 17043677 | ||
| Pubmed | PCYT1A FLNA POGLUT3 RARS1 ERAP1 SPTAN1 CBX3 DNAJB4 PSMD12 WDR3 RACK1 CLTA CHEK2 MANF MACF1 LRPAP1 PDS5A SDF4 PRKDC | 5.61e-06 | 1297 | 155 | 19 | 33545068 | |
| Pubmed | EPRS1 FLNA HK2 PSMA3 SPTAN1 SPTBN1 SAE1 PSMD12 USP14 MDN1 CLTA MACF1 | 5.83e-06 | 538 | 155 | 12 | 28524877 | |
| Pubmed | HK2 ERAP1 ACO2 SPTBN2 MACROH2A1 MDN1 EHD1 CHEK2 MACF1 PDS5A SDF4 ATIC PTCD3 | 5.84e-06 | 634 | 155 | 13 | 34591612 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 PDE3B RARS1 SPTBN2 NARS1 MDN1 PDS5A CHD6 ATIC PRKDC JAKMIP1 PWWP3B CFAP44 LRRFIP2 | 5.94e-06 | 736 | 155 | 14 | 29676528 |
| Pubmed | EPRS1 FLNA SYNE1 ACO2 SPTA1 SPTAN1 SPTBN1 SPTBN2 PSD3 NARS1 DNAJC6 MYEF2 SIRT2 RACK1 EHD1 DLAT MACF1 NME2 LRRFIP2 PTCD3 | 6.26e-06 | 1431 | 155 | 20 | 37142655 | |
| Pubmed | 7.71e-06 | 159 | 155 | 7 | 34537242 | ||
| Pubmed | FLNA RARS1 SYNE1 SPTAN1 MACROH2A1 WDR3 RACK1 LRPAP1 PRKDC NME2 GCN1 | 8.02e-06 | 463 | 155 | 11 | 34901782 | |
| Pubmed | STON1 PODXL BEND3 TBC1D22B SH3BP4 WDR3 ZC3H11A RACK1 EHD1 PDS5A MPHOSPH9 PRKDC GCN1 PTCD3 | 1.09e-05 | 777 | 155 | 14 | 35844135 | |
| Pubmed | SPTAN1 UBAP1 PSMD12 USP37 ZRANB3 MYSM1 USP14 OTULIN DLAT MACF1 RABGEF1 | 1.14e-05 | 481 | 155 | 11 | 28190767 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FLNA DYNC2H1 CBX3 BEND3 PSMD12 USP37 WDR3 S100A8 USP14 MRM3 CLTA MARK4 POLR1B SDF4 MPHOSPH9 GCN1 | 1.18e-05 | 1005 | 155 | 16 | 19615732 |
| Pubmed | 1.20e-05 | 237 | 155 | 8 | 29564676 | ||
| Pubmed | 1.27e-05 | 397 | 155 | 10 | 21319273 | ||
| Interaction | SIRT7 interactions | FLNA SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 BEND3 CHD7 PSMD12 MYEF2 WDR3 S100A8 ZC3H11A MDN1 RACK1 DLAT MACF1 PDS5A ATIC PRKDC GCN1 PTCD3 | 4.34e-08 | 744 | 152 | 22 | int:SIRT7 |
| Interaction | AGR2 interactions | EPRS1 FLNA RARS1 DYNC2H1 SYNE1 ACO2 ANXA4 PSMA3 SPTA1 SPTAN1 SPTBN1 CBX3 PSMD12 MYEF2 S100A8 USP14 MDN1 RACK1 CBX5 MACF1 ATIC PRKDC GCN1 | 5.46e-07 | 934 | 152 | 23 | int:AGR2 |
| Interaction | EED interactions | EPRS1 FLNA HK2 RARS1 SPTAN1 SPTBN1 CBX3 PPHLN1 MACROH2A1 CHD7 PSMD12 VPS16 KIF20B MYEF2 SH3BP4 WDR3 USP14 ZC3H11A SIRT2 RACK1 EHD1 LTN1 MACF1 LRPAP1 PDS5A RABGEF1 ATIC PRKDC LRRFIP2 | 1.08e-06 | 1445 | 152 | 29 | int:EED |
| Interaction | BAP1 interactions | EPRS1 PCYT1A FLNA RARS1 PSMA3 SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 SAE1 DNAJB4 PSMD12 MDN1 RACK1 CBX5 CLTA CHEK2 DLAT MACF1 PDS5A ELK3 ATIC PRKDC NME2 GCN1 PTCD3 | 1.73e-06 | 1314 | 152 | 27 | int:BAP1 |
| Interaction | MKI67 interactions | SMG1 CBX3 BEND3 PPHLN1 CHD7 KIF20B WDR3 PASK ZC3H11A RACK1 CBX5 EHD1 CHEK2 DLAT PDS5A QSER1 DNMBP PTCD3 | 1.98e-06 | 648 | 152 | 18 | int:MKI67 |
| Interaction | BIRC3 interactions | EPRS1 FLNA RARS1 CACNA2D2 DYNC2H1 SYNE1 ACO2 PSMA3 SPTAN1 SPTBN1 CBX3 MACROH2A1 PSMD12 WDR3 S100A8 MRM3 ZC3H11A MDN1 RACK1 CLTA DLAT PDS5A ATIC PRKDC DNAH5 GCN1 PTCD3 | 2.31e-06 | 1334 | 152 | 27 | int:BIRC3 |
| Interaction | SUMO2 interactions | EPRS1 FLNA SP100 HK2 RARS1 ACO2 SPTAN1 SPTBN1 NARS1 SAE1 ZC3H11A MDN1 PDS5A ELK3 ATIC PRKDC GCN1 | 2.44e-06 | 591 | 152 | 17 | int:SUMO2 |
| Interaction | H3C1 interactions | EPRS1 DYNC2H1 SYNE1 ACO2 SPTAN1 CBX3 MACROH2A1 CHD7 KIF20B MYSM1 SIRT2 RACK1 CBX5 WDR87 CDC16 CFDP1 PDS5A PRKDC PWWP3B DNAH8 PTCD3 | 4.23e-06 | 901 | 152 | 21 | int:H3C1 |
| Interaction | YWHAG interactions | FLNA PDE3B RAPGEF6 SPAST SPTAN1 DZIP1L SPTBN1 PSD3 TBC1D22B USP37 SH3BP4 TTBK1 DLC1 MDN1 OSBPL3 MARK4 MACF1 RABGEF1 PRKCQ MPHOSPH9 ATIC PRKDC JAKMIP1 DNMBP CCDC102A | 6.92e-06 | 1248 | 152 | 25 | int:YWHAG |
| Interaction | WDR76 interactions | FLNA SPTAN1 SPTBN1 CBX3 MACROH2A1 CHD7 MDN1 RACK1 CBX5 PDS5A POLR1B PRKDC GCN1 | 6.97e-06 | 383 | 152 | 13 | int:WDR76 |
| Interaction | ULK3 interactions | 7.24e-06 | 62 | 152 | 6 | int:ULK3 | |
| Interaction | IFI16 interactions | FLNA SP100 SYNE1 SPTAN1 NARS1 CBX3 PPHLN1 MACROH2A1 PSMD12 WDR3 S100A8 MRM3 RACK1 CBX5 DLAT POLR1B ATIC LRRFIP2 | 7.59e-06 | 714 | 152 | 18 | int:IFI16 |
| Interaction | TES interactions | EPRS1 FLNA HK2 SPTAN1 SPTBN1 SH3BP4 OTULIN CLTA MACF1 SDF4 PRKDC GCN1 | 8.49e-06 | 332 | 152 | 12 | int:TES |
| Interaction | CFTR interactions | AKAP6 EPRS1 FLNA POGLUT3 RARS1 ERAP1 PSMA3 SPTAN1 SPTBN1 SAE1 PSMD12 SH3BP4 S100A8 FANCB MDN1 OTULIN RACK1 EHD1 CLTA LTN1 DLAT MACF1 PRKDC HSD17B2 GCN1 LRRFIP2 PTCD3 | 1.55e-05 | 1480 | 152 | 27 | int:CFTR |
| Interaction | CDC42 interactions | EPRS1 PCYT1A FLNA PDE3B RARS1 FGD2 DYNC2H1 PODXL SYNE1 ACO2 SPTAN1 SPTBN1 SPTBN2 PSD3 DCBLD1 CBX3 MACROH2A1 PSMD12 SH3BP4 RASIP1 MDN1 MARK4 PRKDC QSER1 DNMBP | 1.87e-05 | 1323 | 152 | 25 | int:CDC42 |
| Interaction | USP14 interactions | FLNA RARS1 PSMA3 SPTAN1 SPTBN1 SPTBN2 NARS1 CBX3 MACROH2A1 PSMD12 USP14 CBX5 MACF1 PRKDC | 2.09e-05 | 489 | 152 | 14 | int:USP14 |
| Interaction | BRCA1 interactions | EPRS1 FLNA HK2 RARS1 ERAP1 SPTAN1 SPTBN1 CBX3 PPHLN1 MACROH2A1 PSMD12 USP37 KIF20B FANCB ZC3H11A MDN1 RACK1 CBX5 CDC16 EHD1 CHEK2 PDS5A PRKDC GCN1 | 2.15e-05 | 1249 | 152 | 24 | int:BRCA1 |
| Interaction | ISG15 interactions | EPRS1 FLNA SPAST RARS1 PSMA3 SPTAN1 DNAJB4 USP14 RACK1 CBX5 ATIC PRKDC GCN1 LRRFIP2 | 2.33e-05 | 494 | 152 | 14 | int:ISG15 |
| Interaction | RCOR1 interactions | FLNA SP100 RAPGEF6 SPTAN1 BEND3 MACROH2A1 CHD7 RABGAP1 DNAJC6 RBM20 KIF20B RABGEF1 CHD6 GCN1 | 2.33e-05 | 494 | 152 | 14 | int:RCOR1 |
| Interaction | BTN3A1 interactions | 2.46e-05 | 23 | 152 | 4 | int:BTN3A1 | |
| Interaction | ACTA1 interactions | TRAF3IP1 SPTA1 SPTAN1 SPTBN2 CBX3 SAE1 RABGAP1 PSMD12 MARK4 MACF1 POLR1B DNMBP | 2.56e-05 | 371 | 152 | 12 | int:ACTA1 |
| Interaction | CHMP4C interactions | EPRS1 FLNA RARS1 SPTAN1 SPTBN1 SPTBN2 CBX3 PPHLN1 MACROH2A1 WDR3 CBX5 WDR87 CLTA MANF MACF1 PRKDC | 6.47e-05 | 687 | 152 | 16 | int:CHMP4C |
| Interaction | CDH1 interactions | FLNA RARS1 ANXA4 SPTAN1 SPTBN1 SPTBN2 TBC1D22B MACROH2A1 USP14 RACK1 EHD1 PAH GM2A MACF1 ATIC PRKDC GCN1 | 7.08e-05 | 768 | 152 | 17 | int:CDH1 |
| Interaction | SVIL interactions | 7.08e-05 | 233 | 152 | 9 | int:SVIL | |
| Interaction | SPAST interactions | 7.83e-05 | 136 | 152 | 7 | int:SPAST | |
| Interaction | RNF8 interactions | PCYT1A ANXA4 SPTAN1 SPTBN1 S100A8 MDN1 RACK1 CLTA CFDP1 CHEK2 ATIC PRKDC | 8.64e-05 | 421 | 152 | 12 | int:RNF8 |
| Interaction | ACE2 interactions | EPRS1 FLNA TUT4 HK2 RARS1 PODXL SPTAN1 SPTBN1 SAE1 MACROH2A1 RABGAP1 PSMD12 BTN3A1 WDR3 S100A8 RACK1 CBX5 DLAT PRKDC NME2 GCN1 | 8.80e-05 | 1106 | 152 | 21 | int:ACE2 |
| Interaction | CTSL interactions | 8.88e-05 | 240 | 152 | 9 | int:CTSL | |
| Interaction | PCNT interactions | AKAP6 TRAF3IP1 SYNE1 SPTAN1 SPTBN1 SPTBN2 DNAJC6 MACF1 MPHOSPH9 | 9.17e-05 | 241 | 152 | 9 | int:PCNT |
| Interaction | MIR363 interactions | 9.37e-05 | 97 | 152 | 6 | int:MIR363 | |
| Interaction | CDCA5 interactions | 9.40e-05 | 140 | 152 | 7 | int:CDCA5 | |
| Interaction | EEF1A1P5 interactions | 9.83e-05 | 141 | 152 | 7 | int:EEF1A1P5 | |
| Interaction | SHANK3 interactions | FLNA TRAF3IP1 SYNE1 SPTAN1 SPTBN1 SPTBN2 PPHLN1 DNAJC6 MYEF2 MRM3 SIRT2 CLTA MACF1 | 1.02e-04 | 496 | 152 | 13 | int:SHANK3 |
| Interaction | MOB3C interactions | EPRS1 PCYT1A RARS1 PSMA3 CBX3 PSMD12 MDN1 CLTA PDS5A PRKDC GCN1 | 1.03e-04 | 364 | 152 | 11 | int:MOB3C |
| Interaction | KCNA3 interactions | DOCK1 EPRS1 RARS1 SPTBN1 PSD3 NARS1 CBX3 PSMD12 RACK1 EHD1 LRP6 MACF1 PDS5A RP1 MPHOSPH9 PRKDC DNAH5 GCN1 | 1.03e-04 | 871 | 152 | 18 | int:KCNA3 |
| Interaction | CUL1 interactions | DOCK1 EPRS1 TUT4 SPAST RARS1 PSMA3 SPTAN1 SPTBN1 CBX3 PSMD12 USP37 MRM3 DLC1 RACK1 CHEK2 DLAT POLR1B PRKDC | 1.10e-04 | 876 | 152 | 18 | int:CUL1 |
| Interaction | MANSC1 interactions | 1.38e-04 | 104 | 152 | 6 | int:MANSC1 | |
| Interaction | OBSL1 interactions | FLNA SYNE1 SPTBN2 CBX3 MACROH2A1 PSMD12 MYEF2 WDR3 PASK ZC3H11A MDN1 RACK1 CBX5 CLTA DLAT MACF1 PRKDC GCN1 | 1.59e-04 | 902 | 152 | 18 | int:OBSL1 |
| Interaction | HCST interactions | 1.68e-04 | 205 | 152 | 8 | int:HCST | |
| Interaction | NLRP8 interactions | 1.69e-04 | 3 | 152 | 2 | int:NLRP8 | |
| Interaction | ATG16L1 interactions | FLNA RARS1 ACO2 PSMA3 NARS1 UBAP1 CBX3 RABGAP1 MYEF2 S100A8 PASK ZC3H11A RACK1 CBX5 CLTA MANF DNMBP NNMT GCN1 LRRFIP2 CCDC102A | 1.73e-04 | 1161 | 152 | 21 | int:ATG16L1 |
| Interaction | SP100 interactions | 1.73e-04 | 206 | 152 | 8 | int:SP100 | |
| Interaction | MYH9 interactions | FLNA TRAF3IP1 PSMA3 SPTAN1 SPTBN1 SPTBN2 MACROH2A1 WDR3 USP14 CLTA MARK4 LTN1 MACF1 DNAH5 LRRFIP2 CCDC102A | 1.89e-04 | 754 | 152 | 16 | int:MYH9 |
| Interaction | PINK1 interactions | EPRS1 FLNA RARS1 SPTAN1 SPTBN1 SPTBN2 S100A8 RACK1 GM2A DLAT ATIC PRKDC NME2 GCN1 PTCD3 | 1.97e-04 | 679 | 152 | 15 | int:PINK1 |
| Interaction | RICTOR interactions | EPRS1 FLNA SP100 HK2 RARS1 PLEKHG7 SPTBN1 ZC3H11A SIRT2 RACK1 CDC16 NXF2 SDF4 PRKDC FUT8 GCN1 | 2.04e-04 | 759 | 152 | 16 | int:RICTOR |
| Interaction | CEBPB interactions | EPRS1 FLNA RARS1 PSMA3 SPTBN2 CBX3 SAE1 BEND3 PPHLN1 MACROH2A1 CHD7 PSMD12 KIF20B USP14 ZC3H11A SIRT2 RACK1 CBX5 CLTA MANF ATIC PRKDC NME2 PTCD3 | 2.04e-04 | 1443 | 152 | 24 | int:CEBPB |
| Interaction | BCL2L1 interactions | 2.18e-04 | 213 | 152 | 8 | int:BCL2L1 | |
| Interaction | CIT interactions | FLNA RARS1 DYNC2H1 SYNE1 SPTAN1 SPTBN1 SPTBN2 ESRP1 NARS1 CBX3 BEND3 MACROH2A1 WDR3 NLRP9 BNIP3L RACK1 CBX5 CLTA MACF1 PDS5A POLR1B ATIC PRKDC GCN1 | 2.20e-04 | 1450 | 152 | 24 | int:CIT |
| Interaction | WDR5 interactions | EPRS1 FLNA RARS1 ACO2 PSMA3 SPTAN1 SPTBN1 NARS1 CBX3 MACROH2A1 CHD7 PSMD12 PASK DLC1 RACK1 EHD1 MANF MACF1 PRKDC GCN1 | 2.36e-04 | 1101 | 152 | 20 | int:WDR5 |
| Interaction | C3orf18 interactions | 2.39e-04 | 115 | 152 | 6 | int:C3orf18 | |
| Interaction | HDLBP interactions | FLNA SPAST SPTAN1 SPTBN1 CBX3 SAE1 CHD7 PSMD12 USP14 MRM3 RACK1 CBX5 EHD1 CLTA PRKDC LRRFIP2 PTCD3 | 2.55e-04 | 855 | 152 | 17 | int:HDLBP |
| Interaction | MIRLET7G interactions | 2.62e-04 | 117 | 152 | 6 | int:MIRLET7G | |
| Interaction | SMC3 interactions | TRAF3IP1 PSD3 USP37 SYCP2 MDN1 CFDP1 CHEK2 PDS5A SDF4 PRKDC GCN1 | 2.76e-04 | 408 | 152 | 11 | int:SMC3 |
| Interaction | DCLRE1C interactions | 3.05e-04 | 43 | 152 | 4 | int:DCLRE1C | |
| Interaction | STAG2 interactions | 3.06e-04 | 224 | 152 | 8 | int:STAG2 | |
| Interaction | METTL14 interactions | FLNA PSMA3 SPTAN1 SPTBN1 CBX3 MACROH2A1 PSMD12 KIF20B RACK1 DLAT PRKDC GCN1 PTCD3 | 3.21e-04 | 558 | 152 | 13 | int:METTL14 |
| Interaction | TCF7L2 interactions | 3.21e-04 | 285 | 152 | 9 | int:TCF7L2 | |
| Interaction | SPTBN2 interactions | 3.34e-04 | 172 | 152 | 7 | int:SPTBN2 | |
| Interaction | TTC41P interactions | 3.36e-04 | 4 | 152 | 2 | int:TTC41P | |
| Interaction | WAPL interactions | 3.46e-04 | 173 | 152 | 7 | int:WAPL | |
| Interaction | PARP1 interactions | HK2 ANXA4 SPTA1 NARS1 CBX3 BEND3 MACROH2A1 CHD7 ACAD10 PSMD12 MYSM1 SH3BP4 WDR3 USP14 SIRT2 MDN1 CBX5 DLAT PDS5A POLR1B CHD6 PRKDC | 3.60e-04 | 1316 | 152 | 22 | int:PARP1 |
| Interaction | PMF1-BGLAP interactions | 3.73e-04 | 19 | 152 | 3 | int:PMF1-BGLAP | |
| Interaction | CAV1 interactions | FLNA RAPGEF6 SPTAN1 SPTBN1 SPTBN2 PSD3 TBC1D22B PSMD12 SH3BP4 DLC1 EHD1 LRP6 MACF1 RABGEF1 ATIC | 3.89e-04 | 724 | 152 | 15 | int:CAV1 |
| Interaction | TBCK interactions | 3.91e-04 | 82 | 152 | 5 | int:TBCK | |
| Interaction | CBX3 interactions | SP100 RARS1 CBX3 MACROH2A1 CHD7 USP37 MYSM1 WDR3 USP14 OXCT1 CBX5 CFDP1 MACF1 PDS5A | 3.91e-04 | 646 | 152 | 14 | int:CBX3 |
| Interaction | SLX4 interactions | FLNA RARS1 PSMA3 CBX3 BEND3 PPHLN1 S100A8 MDN1 RACK1 PDS5A PRKDC NME2 GCN1 | 4.06e-04 | 572 | 152 | 13 | int:SLX4 |
| Interaction | BCL2L14 interactions | 4.07e-04 | 127 | 152 | 6 | int:BCL2L14 | |
| Interaction | SOX2 interactions | EPRS1 FLNA RARS1 ANXA4 SPTAN1 SPTBN1 SPTBN2 CBX3 MACROH2A1 CHD7 PSMD12 MYEF2 WDR3 OXCT1 MDN1 RACK1 CBX5 TEKT1 MACF1 CHD6 QSER1 GCN1 PTCD3 | 4.18e-04 | 1422 | 152 | 23 | int:SOX2 |
| Interaction | DISC1 interactions | AKAP6 FLNA TRAF3IP1 SYNE1 SPTAN1 SPTBN1 RABGAP1 TRIM68 VPS16 CDC16 MACF1 | 4.22e-04 | 429 | 152 | 11 | int:DISC1 |
| Interaction | CEBPA interactions | EPRS1 FLNA SPAST RARS1 PSMA3 SPTAN1 SPTBN1 NARS1 SAE1 BEND3 CHD7 PSMD12 USP14 ZC3H11A CLTA MACF1 PDS5A ATIC PRKDC QSER1 NME2 | 4.41e-04 | 1245 | 152 | 21 | int:CEBPA |
| Interaction | TUBB interactions | PI4K2B EPRS1 RARS1 TRAF3IP1 PLEKHG7 ACO2 CBX3 MACROH2A1 PSMD12 S100A8 TTBK1 MDN1 RACK1 MARK4 LTN1 | 4.55e-04 | 735 | 152 | 15 | int:TUBB |
| Interaction | MIR9-1 interactions | 4.61e-04 | 85 | 152 | 5 | int:MIR9-1 | |
| Interaction | BMI1 interactions | SYNE1 SPTBN1 ESRP1 CBX3 PPHLN1 MACROH2A1 MYEF2 ZC3H11A RACK1 CBX5 PRKDC GCN1 CCDC102A PTCD3 | 4.77e-04 | 659 | 152 | 14 | int:BMI1 |
| Interaction | C19orf38 interactions | 4.87e-04 | 86 | 152 | 5 | int:C19orf38 | |
| Interaction | MAS1 interactions | 4.87e-04 | 86 | 152 | 5 | int:MAS1 | |
| Interaction | ITGB2 interactions | 5.00e-04 | 132 | 152 | 6 | int:ITGB2 | |
| Interaction | MYO18A interactions | 5.01e-04 | 303 | 152 | 9 | int:MYO18A | |
| Interaction | IQCB1 interactions | 5.14e-04 | 370 | 152 | 10 | int:IQCB1 | |
| Interaction | MAPRE1 interactions | FLNA SPTAN1 SPTBN1 MACROH2A1 PSMD12 DNAJC6 MRM3 TTBK1 CLTA MACF1 JAKMIP1 DNMBP | 5.36e-04 | 514 | 152 | 12 | int:MAPRE1 |
| Interaction | MIR141 interactions | 5.41e-04 | 88 | 152 | 5 | int:MIR141 | |
| Interaction | PSPC1 interactions | EPRS1 SP100 SPAST RARS1 ESRP1 DNAJB4 WDR3 MRM3 RACK1 CDC16 LRPAP1 QSER1 | 5.46e-04 | 515 | 152 | 12 | int:PSPC1 |
| Interaction | SPTBN4 interactions | 5.47e-04 | 50 | 152 | 4 | int:SPTBN4 | |
| Interaction | FANCC interactions | 5.70e-04 | 89 | 152 | 5 | int:FANCC | |
| Interaction | H2BC9 interactions | EPRS1 PNLIPRP1 TRAF3IP1 SPTAN1 MACROH2A1 ADGRG4 CFDP1 DLAT RP1 CFAP44 DNAH5 | 5.83e-04 | 446 | 152 | 11 | int:H2BC9 |
| Interaction | MAU2 interactions | 5.86e-04 | 136 | 152 | 6 | int:MAU2 | |
| Interaction | RHOF interactions | PCYT1A PODXL SPTAN1 SPTBN1 SPTBN2 PSD3 DCBLD1 SAE1 SH3BP4 MDN1 EHD1 MACF1 PRKDC QSER1 | 5.87e-04 | 673 | 152 | 14 | int:RHOF |
| Interaction | CENPA interactions | PCYT1A CBX3 BEND3 MACROH2A1 CHD7 MYSM1 CBX5 PDS5A CHD6 PRKDC | 5.95e-04 | 377 | 152 | 10 | int:CENPA |
| Cytoband | 6p21.2 | 2.48e-04 | 36 | 155 | 3 | 6p21.2 | |
| Cytoband | 11q23.1 | 2.70e-04 | 37 | 155 | 3 | 11q23.1 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.04e-08 | 7 | 100 | 4 | 1113 | |
| GeneFamily | NLR family | 3.46e-04 | 25 | 100 | 3 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 3.46e-04 | 25 | 100 | 3 | 994 | |
| GeneFamily | Chromobox family | 8.30e-04 | 8 | 100 | 2 | 976 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.97e-04 | 206 | 100 | 6 | 682 | |
| GeneFamily | ESCRT-I | 1.06e-03 | 9 | 100 | 2 | 1116 | |
| GeneFamily | EF-hand domain containing | 1.36e-03 | 219 | 100 | 6 | 863 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.82e-03 | 51 | 100 | 3 | 870 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.15e-03 | 53 | 100 | 3 | 532 | |
| GeneFamily | Dyneins, axonemal | 3.90e-03 | 17 | 100 | 2 | 536 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 4.87e-03 | 19 | 100 | 2 | 132 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 4.87e-03 | 19 | 100 | 2 | 131 | |
| Coexpression | LEE_BMP2_TARGETS_DN | PDE3B FOXRED1 HK2 DCBLD1 NARS1 BEND3 PSMD12 TRIM59 WDR3 S100A8 MRM3 FANCB MDN1 EHD1 MANF DLAT PDS5A POLR1B ATIC LY75 FUT8 PTCD3 | 1.96e-08 | 904 | 155 | 22 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | PDE3B FOXRED1 HK2 DCBLD1 NARS1 BEND3 PSMD12 TRIM59 WDR3 S100A8 MRM3 FANCB MDN1 EHD1 MANF DLAT PDS5A POLR1B ATIC LY75 FUT8 PTCD3 | 2.77e-08 | 922 | 155 | 22 | MM1068 |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | PCYT1A RAPGEF6 MACROH2A1 CHD7 USP37 RABGEF1 PRKCQ JAKMIP1 PWWP3B SMAD5 | 8.23e-08 | 172 | 155 | 10 | M8234 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | EPRS1 PODXL SPTBN1 CBX3 MDN1 CBX5 MACF1 PDS5A PRKDC FUT8 GCN1 | 3.08e-07 | 250 | 155 | 11 | M11318 |
| Coexpression | GSE27786_CD4_TCELL_VS_MONO_MAC_UP | SMG1 ERAP1 PSMA3 MACROH2A1 PSMD12 VPS16 TRIM59 MYEF2 MANF CHD6 | 3.36e-07 | 200 | 155 | 10 | M4833 |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_DN | 3.02e-06 | 199 | 155 | 9 | M5729 | |
| Coexpression | GSE27786_LSK_VS_MONO_MAC_UP | 3.15e-06 | 200 | 155 | 9 | M4763 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 SP100 TUT4 SPAST PODXL PSD3 TOGARAM1 RABGAP1 KIF20B DLC1 MDN1 CDC16 LTN1 MACF1 PDS5A MPHOSPH9 FUT8 DNMBP | 3.36e-06 | 856 | 155 | 18 | M4500 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | FLNA HK2 ACO2 ANXA4 PSMA3 SPTA1 SPTBN2 CBX3 PSMD12 WDR3 USP14 BNIP3L OXCT1 DLC1 CDC16 EHD1 CFDP1 GM2A SDF4 PRKCQ ATIC PRKDC LRRFIP2 | 8.44e-06 | 1399 | 155 | 23 | M535 |
| Coexpression | GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 8.86e-06 | 172 | 155 | 8 | M9089 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SMG1 EPRS1 SPAST ERAP1 ANXA4 SPTBN1 UBAP1 SAE1 CFAP298 SH3BP4 WDR3 OXCT1 MDN1 CDC16 CLTA LTN1 MANF MACF1 PRKDC LRRFIP2 GNPAT | 1.03e-05 | 1215 | 155 | 21 | M41122 |
| Coexpression | EPPERT_PROGENITOR | 1.87e-05 | 138 | 155 | 7 | M19232 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 FLNA TUT4 RAPGEF6 ERAP1 SYNE1 SPTAN1 TMC6 CBX3 NLRP1 PPHLN1 BTN3A1 MYSM1 ZC3H11A TRANK1 RACK1 CDC16 CD101 EHD1 MACF1 PDS5A PRKCQ MVB12B | 2.35e-05 | 1492 | 155 | 23 | M40023 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 2.45e-05 | 198 | 155 | 8 | M8274 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | TRAF3IP1 DYNC2H1 PLEKHG7 SYNE1 ANXA4 DZIP1L SPTBN1 PSD3 MYEF2 BCO2 OSBPL3 CDC16 CLTA CFDP1 TEKT1 ELK3 RP1 CFAP44 DNAH5 | 2.61e-05 | 1093 | 155 | 19 | M41649 |
| Coexpression | GSE1460_DP_VS_CD4_THYMOCYTE_DN | 2.64e-05 | 200 | 155 | 8 | M3454 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP | 2.64e-05 | 200 | 155 | 8 | M3719 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN | 2.64e-05 | 200 | 155 | 8 | M5068 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | EPRS1 FOXRED1 RARS1 PSMA3 SPTA1 SPTBN2 NARS1 CBX3 PSMD12 DNAJC6 CFAP298 KIF20B USP14 MDN1 CDC16 CLTA CHEK2 ATIC PRKDC PTCD3 | 6.36e-05 | 1271 | 155 | 20 | M39197 |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN | 7.09e-05 | 170 | 155 | 7 | M6762 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | 9.31e-05 | 307 | 155 | 9 | M19745 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.01e-04 | 180 | 155 | 7 | M8239 | |
| Coexpression | WIERENGA_PML_INTERACTOME | 1.11e-04 | 42 | 155 | 4 | M2219 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 1.16e-04 | 184 | 155 | 7 | M9005 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN | 1.33e-04 | 188 | 155 | 7 | M40862 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | EPRS1 SP100 RARS1 CBX3 RABGAP1 USP14 BNIP3L RACK1 MACF1 PRKDC GNPAT | 1.43e-04 | 481 | 155 | 11 | M3898 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | SMG1 ANXA4 PSMA3 NARS1 CBX3 USP14 OXCT1 RACK1 CFDP1 LTN1 LY75 SMAD5 | 1.50e-04 | 568 | 155 | 12 | M4023 |
| Coexpression | GSE12366_GC_BCELL_VS_PLASMA_CELL_DN | 1.61e-04 | 194 | 155 | 7 | M3167 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP | 1.67e-04 | 195 | 155 | 7 | M3089 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 1.83e-04 | 198 | 155 | 7 | M7200 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP | 1.83e-04 | 198 | 155 | 7 | M4478 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | SMG1 EPRS1 ABCA3 ANXA4 SPTBN1 DCBLD1 ZC3H11A GM2A ELK3 NNMT SMAD5 | 1.84e-04 | 495 | 155 | 11 | M8451 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP | 1.89e-04 | 199 | 155 | 7 | M8002 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 1.89e-04 | 199 | 155 | 7 | M4571 | |
| Coexpression | GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN | 1.89e-04 | 199 | 155 | 7 | M6351 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.89e-04 | 199 | 155 | 7 | M5893 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP | 1.89e-04 | 199 | 155 | 7 | M3087 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP | 1.95e-04 | 200 | 155 | 7 | M3326 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN | 1.95e-04 | 200 | 155 | 7 | M5975 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 1.95e-04 | 200 | 155 | 7 | M5991 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 1.95e-04 | 200 | 155 | 7 | M9327 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP | 1.95e-04 | 200 | 155 | 7 | M4574 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_DN | 1.95e-04 | 200 | 155 | 7 | M8261 | |
| Coexpression | GSE27786_LSK_VS_NEUTROPHIL_UP | 1.95e-04 | 200 | 155 | 7 | M4760 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP | 1.95e-04 | 200 | 155 | 7 | M4790 | |
| Coexpression | GSE17186_MEMORY_VS_NAIVE_BCELL_UP | 1.95e-04 | 200 | 155 | 7 | M7170 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP | 1.95e-04 | 200 | 155 | 7 | M8698 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN | 1.95e-04 | 200 | 155 | 7 | M6020 | |
| Coexpression | GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP | 1.95e-04 | 200 | 155 | 7 | M8957 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN | 1.95e-04 | 200 | 155 | 7 | M6601 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_DC_UP | 1.95e-04 | 200 | 155 | 7 | M4490 | |
| Coexpression | GSE7852_LN_VS_FAT_TREG_DN | 1.95e-04 | 200 | 155 | 7 | M5742 | |
| Coexpression | GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN | 1.95e-04 | 200 | 155 | 7 | M6989 | |
| Coexpression | IBRAHIM_NRF1_UP | PCYT1A RARS1 NARS1 DNAJC6 WDR3 USP14 ZC3H11A MANF DLAT LRRFIP2 | 2.09e-04 | 420 | 155 | 10 | M42509 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | HK2 SPAST ANXA4 PSMA3 SPTAN1 SPTBN1 CHD7 ZC3H11A OXCT1 CDC16 MACF1 PDS5A MPHOSPH9 PRKDC | 2.62e-04 | 790 | 155 | 14 | M12490 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | PODXL TRIM59 RBM20 FER1L6 PASK FANCB OXCT1 RACK1 CBX5 OSBPL3 PRKCQ ELK3 PRKDC CCDC102A MVB12B | 2.72e-04 | 891 | 155 | 15 | M45033 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | POGLUT3 PODXL SPTBN1 DNAJB4 TBC1D22B CHD7 TRIM68 TRIM59 KIF20B SH3BP4 USP14 PASK MANF MACF1 LRRFIP2 | 2.76e-04 | 892 | 155 | 15 | M18120 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | EPRS1 CBX3 SAE1 CHD7 WDR3 MDN1 RACK1 CHEK2 ATIC PRKDC NME2 GCN1 | 2.96e-04 | 612 | 155 | 12 | M4772 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | SMG1 PDE3B TUT4 RAPGEF6 TOGARAM1 CHD7 MDN1 MACF1 PRKCQ PRKDC LY75 DNAH8 TDRP | 1.09e-06 | 336 | 154 | 13 | GSM538413_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | SMG1 SP100 PDE3B TUT4 RAPGEF6 CHD7 MDN1 MACF1 PRKCQ LY75 DNAH8 TDRP | 3.60e-06 | 317 | 154 | 12 | GSM538412_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | EPRS1 POGLUT3 PDE3B RAPGEF6 TRAF3IP1 NARS1 TOGARAM1 PPHLN1 MACROH2A1 CHD7 ZC3H11A CFDP1 CHEK2 DLAT MACF1 QSER1 | 3.61e-06 | 564 | 154 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | SP100 PDE3B RAPGEF6 TBC1D22B CHD7 MDN1 MACF1 PRKCQ JAKMIP1 LY75 DNAH8 TDRP | 6.91e-06 | 338 | 154 | 12 | GSM403987_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3 | SP100 PDE3B RAPGEF6 TBC1D22B CHD7 MDN1 MACF1 PRKCQ LY75 DNAH8 TDRP | 1.37e-05 | 303 | 154 | 11 | GSM538398_500 |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 3.88e-05 | 224 | 154 | 9 | GSM403994_500 | |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | SP100 PDE3B RAPGEF6 CHD7 MDN1 RACK1 POLR1B PRKCQ LY75 DNAH8 TDRP | 6.30e-05 | 358 | 154 | 11 | GSM605909_500 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 1.42e-04 | 327 | 154 | 10 | GSM538380_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.LN, CD8 TCRb CD44high CD122high, Lymph Node, avg-3 | 1.49e-04 | 329 | 154 | 10 | GSM538395_500 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 1.52e-04 | 210 | 154 | 8 | GSM403995_500 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | AKAP6 DYNC2H1 SYNE1 DZIP1L SLC9C2 MYEF2 OSBPL3 RP1 CFAP44 DNAH5 | 1.95e-09 | 197 | 155 | 10 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.19e-08 | 197 | 155 | 9 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.63e-08 | 200 | 155 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.63e-08 | 200 | 155 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.77e-07 | 184 | 155 | 8 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-07 | 194 | 155 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.47e-07 | 196 | 155 | 8 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.47e-07 | 196 | 155 | 8 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.47e-07 | 196 | 155 | 8 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.47e-07 | 196 | 155 | 8 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.65e-07 | 197 | 155 | 8 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-07 | 197 | 155 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-07 | 197 | 155 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-07 | 197 | 155 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.21e-07 | 200 | 155 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.21e-07 | 200 | 155 | 8 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.21e-07 | 200 | 155 | 8 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.01e-06 | 167 | 155 | 7 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-06 | 176 | 155 | 7 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.95e-06 | 177 | 155 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.95e-06 | 177 | 155 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 2.95e-06 | 177 | 155 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.95e-06 | 177 | 155 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.95e-06 | 177 | 155 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.42e-06 | 181 | 155 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-06 | 182 | 155 | 7 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.55e-06 | 182 | 155 | 7 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-06 | 182 | 155 | 7 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-06 | 182 | 155 | 7 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 3.68e-06 | 183 | 155 | 7 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-06 | 188 | 155 | 7 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.22e-06 | 193 | 155 | 7 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.22e-06 | 193 | 155 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.22e-06 | 193 | 155 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.22e-06 | 193 | 155 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.40e-06 | 194 | 155 | 7 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.40e-06 | 194 | 155 | 7 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-06 | 194 | 155 | 7 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.58e-06 | 195 | 155 | 7 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-06 | 195 | 155 | 7 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 5.58e-06 | 195 | 155 | 7 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.58e-06 | 195 | 155 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 5.58e-06 | 195 | 155 | 7 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.77e-06 | 196 | 155 | 7 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-06 | 196 | 155 | 7 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-06 | 196 | 155 | 7 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-06 | 196 | 155 | 7 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.77e-06 | 196 | 155 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.97e-06 | 197 | 155 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.97e-06 | 197 | 155 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.97e-06 | 197 | 155 | 7 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.97e-06 | 197 | 155 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.97e-06 | 197 | 155 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 198 | 155 | 7 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.17e-06 | 198 | 155 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 6.17e-06 | 198 | 155 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 200 | 155 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 200 | 155 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.59e-06 | 200 | 155 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 200 | 155 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 200 | 155 | 7 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 6.59e-06 | 200 | 155 | 7 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.59e-06 | 200 | 155 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 6.59e-06 | 200 | 155 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | ASK454-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.14e-05 | 144 | 155 | 6 | 8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 159 | 155 | 6 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 164 | 155 | 6 | 83141be8dfed85511ea6afda7c76ff4b6b5ef021 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-05 | 169 | 155 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-05 | 169 | 155 | 6 | 1de3ae36d3b60e961bfd9f7bdc37867b82a0417f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.02e-05 | 171 | 155 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.02e-05 | 171 | 155 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 176 | 155 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.66e-05 | 177 | 155 | 6 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.66e-05 | 177 | 155 | 6 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 178 | 155 | 6 | 1a578d16008a450c42e73a996247ffecdc2c43f0 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 182 | 155 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 182 | 155 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 4.41e-05 | 183 | 155 | 6 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-05 | 184 | 155 | 6 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.69e-05 | 185 | 155 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.69e-05 | 185 | 155 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.83e-05 | 186 | 155 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 186 | 155 | 6 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.83e-05 | 186 | 155 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Lung-30m-Hematologic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.12e-05 | 188 | 155 | 6 | 614b6b83b54bceaf213698310cbb97139bf8dce2 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 5.12e-05 | 188 | 155 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | 4dc89c7843ebd078e3414e835c56f11fa27f0c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | d577b3c2a844e3062c7ca9e9ebc1722d0ac95caa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | 1e788b60dd643bf220d8dfafa82d85fd083cbc71 | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 5.28e-05 | 189 | 155 | 6 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.43e-05 | 190 | 155 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.43e-05 | 190 | 155 | 6 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 191 | 155 | 6 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 191 | 155 | 6 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.59e-05 | 191 | 155 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 191 | 155 | 6 | 326b4541069efedc8ab409f85bb11f77346dda90 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.76e-05 | 192 | 155 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 5.76e-05 | 192 | 155 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.76e-05 | 192 | 155 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 193 | 155 | 6 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; MCF7; HT_HG-U133A | SP100 PDE3B DYNC2H1 PODXL DNAJB4 S100A8 PASK SYCP2 SIRT2 MACF1 | 9.43e-07 | 195 | 155 | 10 | 3451_DN |
| Drug | Iopromide [73334-07-3]; Down 200; 5uM; MCF7; HT_HG-U133A | TBC1D19 PDE3B SPAST CACNA2D2 PSD3 DNAJB4 RABGAP1 S100A8 MARK4 GM2A | 1.04e-06 | 197 | 155 | 10 | 6842_DN |
| Drug | chlorpropamide; Down 200; 100uM; MCF7; HG-U133A | 1.19e-06 | 200 | 155 | 10 | 141_DN | |
| Drug | ADPribulose | 1.41e-06 | 13 | 155 | 4 | CID000197570 | |
| Drug | PRODAN | 2.66e-06 | 15 | 155 | 4 | CID000028127 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.12e-06 | 180 | 155 | 9 | 2639_UP | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.31e-06 | 181 | 155 | 9 | 5743_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A | 5.15e-06 | 185 | 155 | 9 | 2927_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 8.23e-06 | 196 | 155 | 9 | 7128_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 9.30e-06 | 199 | 155 | 9 | 6265_DN | |
| Drug | plakin | 2.07e-05 | 82 | 155 | 6 | CID000018752 | |
| Drug | queuosine | 3.21e-05 | 27 | 155 | 4 | CID000042119 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.48e-05 | 181 | 155 | 8 | 6276_UP | |
| Drug | Calix[4]arene | 4.91e-05 | 11 | 155 | 3 | CID000562409 | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.91e-05 | 190 | 155 | 8 | 4115_DN | |
| Drug | dimethyl adipimidate | 4.93e-05 | 30 | 155 | 4 | CID000025738 | |
| Drug | AGN 193109 | 5.63e-05 | 31 | 155 | 4 | CID000177238 | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 5.69e-05 | 194 | 155 | 8 | 2742_DN | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; PC3; HT_HG-U133A | 5.89e-05 | 195 | 155 | 8 | 5078_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 5.89e-05 | 195 | 155 | 8 | 7318_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; PC3; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 2047_UP | |
| Drug | Famotidine [76824-35-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 5011_DN | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 5072_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 2080_UP | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; HL60; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 2334_UP | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 5340_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; PC3; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 4017_UP | |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 5825_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; HL60; HG-U133A | 6.33e-05 | 197 | 155 | 8 | 1750_DN | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 6681_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 6523_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 6260_DN | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 1868_DN | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; MCF7; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 6878_DN | |
| Drug | leukotoxin B (12,13-EODE); Down 200; 0.2uM; MCF7; HT_HG-U133A_EA | 6.80e-05 | 199 | 155 | 8 | 1108_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HG-U133A | 6.80e-05 | 199 | 155 | 8 | 1960_DN | |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; MCF7; HT_HG-U133A | 7.04e-05 | 200 | 155 | 8 | 6016_UP | |
| Disease | Malignant neoplasm of breast | AKAP6 FLNA ABCA3 SPAST PNLIPRP1 DYNC2H1 SYNE1 ACO2 SPTAN1 PPHLN1 ZNF25 NLRP9 ZC3H11A CHEK2 MACF1 ELK3 NLRP8 | 5.30e-05 | 1074 | 155 | 17 | C0006142 |
| Disease | Atypical juvenile parkinsonism | 8.20e-05 | 3 | 155 | 2 | C4510873 | |
| Disease | Colorectal Carcinoma | AKAP6 ABCA3 SYNE1 SPTBN2 SETD4 DLC1 CBX5 CHEK2 SDF4 JAKMIP1 NME2 DNAH8 NLRP8 | 9.09e-05 | 702 | 155 | 13 | C0009402 |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.63e-04 | 4 | 155 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease, coronary artery disease | 1.63e-04 | 4 | 155 | 2 | EFO_0000341, EFO_0001645 | |
| Disease | bipolar disorder | AKAP6 PDE3B PODXL SYNE1 SPTBN2 DCBLD1 BTN3A1 RASIP1 TRANK1 DLC1 MVB12B | 2.49e-04 | 577 | 155 | 11 | MONDO_0004985 |
| Disease | urate measurement, bone density | AKAP6 PDE3B B3GNTL1 PODXL SYNE1 PSD3 USP14 MARK4 PRKDC DNAH8 LRRFIP2 | 4.51e-04 | 619 | 155 | 11 | EFO_0003923, EFO_0004531 |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.66e-04 | 7 | 155 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | RAPGEF6 B3GNTL1 STON1 CACNA2D2 PLEKHG7 RABGAP1 TRIM59 RASIP1 CFDP1 CHEK2 LY75 DNMBP GCN1 | 1.01e-03 | 904 | 155 | 13 | EFO_0004736 |
| Disease | renal cell carcinoma | 1.40e-03 | 42 | 155 | 3 | EFO_0000681 | |
| Disease | childhood gender nonconformity | 1.50e-03 | 43 | 155 | 3 | EFO_0020103 | |
| Disease | Adenocarcinoma of large intestine | 1.67e-03 | 96 | 155 | 4 | C1319315 | |
| Disease | mean corpuscular hemoglobin concentration | STON1 PSMA3 SPTA1 TMC6 PSD3 BEND3 ACAD10 BNIP3L CBX5 CHEK2 MACF1 PRKDC LY75 CCDC102A | 2.13e-03 | 1105 | 155 | 14 | EFO_0004528 |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 2.39e-03 | 14 | 155 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | X-21470 measurement | 2.39e-03 | 14 | 155 | 2 | EFO_0800817 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 2.39e-03 | 14 | 155 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | Majewski Syndrome | 2.39e-03 | 14 | 155 | 2 | C0024507 | |
| Disease | red blood cell density measurement | POGLUT3 STON1 PODXL PSMA3 SPTA1 SPTBN1 TMC6 ACAD10 KIF20B BNIP3L MARK4 LY75 | 2.44e-03 | 880 | 155 | 12 | EFO_0007978 |
| Disease | lymphocyte percentage of leukocytes | SPTA1 SAE1 BEND3 MACROH2A1 CHD7 VPS16 BNIP3L MARK4 PRKDC LY75 | 2.80e-03 | 665 | 155 | 10 | EFO_0007993 |
| Disease | Metastatic melanoma | 2.90e-03 | 54 | 155 | 3 | C0278883 | |
| Disease | mean platelet volume | PCYT1A ERAP1 SPTA1 SPTBN1 PSD3 MACROH2A1 CHD7 RASIP1 TRANK1 MARK4 CHEK2 LY75 SMAD5 | 2.91e-03 | 1020 | 155 | 13 | EFO_0004584 |
| Disease | factor VIII measurement, coronary artery disease | 3.03e-03 | 113 | 155 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | complex trait | 3.17e-03 | 271 | 155 | 6 | EFO_0010578 | |
| Disease | serum gamma-glutamyl transferase measurement | PSD3 NARS1 NLRP1 TRIM59 S100A8 RASIP1 TRANK1 CHEK2 RP1 JAKMIP1 DNMBP GCN1 | 3.31e-03 | 914 | 155 | 12 | EFO_0004532 |
| Disease | Colorectal Neoplasms | 3.53e-03 | 277 | 155 | 6 | C0009404 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 3.54e-03 | 17 | 155 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | chronic obstructive pulmonary disease | AKAP6 ABCA3 STON1 ACAD10 DLC1 CFDP1 GM2A MPHOSPH9 QSER1 DNAH5 | 3.56e-03 | 688 | 155 | 10 | EFO_0000341 |
| Disease | Bone marrow hypocellularity | 3.97e-03 | 18 | 155 | 2 | C1855710 | |
| Disease | platelet crit | POGLUT3 STON1 ERAP1 TMC6 TBC1D22B SH3BP4 MARK4 CHEK2 POLR1B RP1 MPHOSPH9 LY75 | 4.57e-03 | 952 | 155 | 12 | EFO_0007985 |
| Disease | BRCAX breast cancer | 4.90e-03 | 20 | 155 | 2 | EFO_0009443 | |
| Disease | mean arterial pressure | 5.01e-03 | 499 | 155 | 8 | EFO_0006340 | |
| Disease | neutrophil percentage of leukocytes | 5.09e-03 | 610 | 155 | 9 | EFO_0007990 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FDKWDGKDLEDLQIL | 571 | Q99798 | |
| DNWVKDRKKEFEELI | 276 | Q9BRK5 | |
| KWKDSDEADLVLAKE | 141 | Q13185 | |
| KWKDTDEADLVLAKE | 141 | P45973 | |
| VVGVKLDLEAWAEKF | 841 | Q9NY47 | |
| EWKKALFKPADVILD | 331 | O00481 | |
| WDGVKGKLELFLNKE | 126 | Q8IZF6 | |
| WGADKCEELLEKTVK | 281 | O75367 | |
| DLSWAKVFGILEKAK | 1656 | Q99758 | |
| IEDLKEKAKAEGLWN | 701 | Q6JQN1 | |
| VLAVVDEFWLLGKKE | 31 | Q6XZF7 | |
| KALWVEERALLEGEK | 161 | Q6NSX1 | |
| AGEKKWGTDEVKFLT | 181 | P09525 | |
| LAWKKLKLDGLDEDG | 91 | P30533 | |
| VWAEVSEKALDLVKK | 451 | O96017 | |
| LEKTEKVDWSKFIAV | 206 | Q9BYV7 | |
| WDKEADKSLLIGVFK | 1786 | Q9P2D1 | |
| VEKELAWEKEKHELG | 1001 | Q96MT7 | |
| AKLGSDEKELILLFW | 21 | Q6NXG1 | |
| IKEAVWEKIKEIGDR | 606 | Q5U651 | |
| VFDLKDWELHVKGKL | 421 | Q5T481 | |
| GKEAAEKVSWIKDKL | 436 | Q29RF7 | |
| IKIWDLEGKIIVDEL | 256 | P63244 | |
| KNVKWVEDLFEKFGE | 1711 | Q2KHR3 | |
| AKKLEKDLIDWTDGI | 431 | Q9UJ41 | |
| KIIISWKKEHEDIFL | 1191 | O94822 | |
| AEKEISLWFKPEELV | 126 | P22392 | |
| SKKIWLVPIDFDKLE | 526 | Q5T5X7 | |
| KEQEWTKLYGEIDKL | 256 | Q8IYY4 | |
| KECAEKILETWGELL | 531 | Q9Y3P9 | |
| ERLKDKWDELKEAGV | 426 | O00592 | |
| NEKFEEKWSKILELL | 306 | Q96EY7 | |
| VVKFIKKEKVLEDCW | 1026 | Q96RG2 | |
| GEKERSLFESAWKKE | 561 | Q8TDR0 | |
| WLEKEAKDLLVKLFV | 601 | Q04759 | |
| KDSETGLLIKEKWEA | 781 | Q9NU22 | |
| KWVLGKEDLEEAKLD | 466 | Q86W28 | |
| KFSELWIVEKGIKDV | 181 | O95786 | |
| LDESILLKWTKGFKA | 611 | P52789 | |
| KEKLQWLLDESFKGD | 811 | Q9NZ08 | |
| KVEEKSIDLIQKWEE | 266 | P49585 | |
| NLKLEELEWKLAEVG | 186 | Q8N4E4 | |
| AKLDVGTIEKVKFLW | 406 | P54315 | |
| WEKKEGDKINEGDLI | 111 | P10515 | |
| IWKEIVEEEEKCKAD | 1071 | Q13370 | |
| LQELEKWLKKEPEAF | 91 | P40261 | |
| VKDKKDETLVWEALV | 1336 | Q9C000 | |
| KTLWTEDRDVKVKEF | 1011 | Q96JB1 | |
| DLGLWEEKFGKFVDI | 191 | Q8TET4 | |
| EVERLATELEKWKEK | 1401 | Q96Q89 | |
| QKLEAKEISGVEDWK | 471 | Q99550 | |
| ALKELDEGKIFKNWG | 746 | Q99550 | |
| EGKIYWGDAKTDKIE | 501 | O75581 | |
| EKSALEKIKEEWNFV | 36 | Q9BYS8 | |
| LKEKEGIAKIFWIGL | 266 | O60449 | |
| WVVKFDKEEEIRKLA | 1131 | Q92616 | |
| KLLVEKGQDSKWVEE | 541 | Q96N16 | |
| FGSTEEGEKRWKDLK | 341 | O00232 | |
| EEEKKTWGTVFKTLK | 181 | P00439 | |
| KEVFDLQETLLWKDK | 471 | Q9Y608 | |
| RVKELKKILDDWGET | 136 | P55145 | |
| EIKFLDVLELAEKFW | 5996 | Q9UPN3 | |
| VDADLWKDGLFKSKV | 76 | Q9H7P6 | |
| KWEKLSLVLIDDFIG | 321 | Q8NB91 | |
| KESKWIDDEEFLIKI | 326 | Q8TCG2 | |
| EVKELVWGEDLDKNF | 166 | Q5VZV1 | |
| WKLGLKFDGKNEDLV | 171 | Q96BN8 | |
| LEEWTKSAGLEKFDL | 3226 | Q8NCM8 | |
| AEKWFLDALEKIKAI | 421 | Q13042 | |
| EELKLKDEWGEKCVP | 71 | P57076 | |
| EDKILTIEIKKGWKE | 196 | Q9UDY4 | |
| LEKSKLDWESFKEEE | 241 | Q9UEE9 | |
| KVEGVWLKDGKEITD | 541 | Q8N9C0 | |
| TRKEKALWVDLKEAG | 991 | Q93033 | |
| EAHEKIEKLKDLIAW | 1556 | Q14185 | |
| SKELKKWDEFEDILE | 26 | O15228 | |
| DFDALVEKTLWLKGL | 401 | O15228 | |
| WELVVELKKFKRVEE | 241 | Q96BQ5 | |
| WAKIAELDTEAKNEK | 1026 | Q8TD26 | |
| KGDEKIKSFIWELIT | 1146 | Q8TD26 | |
| KDKGEYTLVVKWGDE | 2621 | P21333 | |
| EKLEGELSQWKIKYE | 281 | Q96A19 | |
| FSLDWDGKVSEIKKK | 26 | Q96CU9 | |
| DPEKLKILEWIEGKE | 816 | O75061 | |
| EGEKEVEALKKSADW | 126 | O60238 | |
| GEFKLLKAEEVAKLW | 31 | P41970 | |
| KDKWINIGYEGEELK | 306 | Q96L34 | |
| FKAETEELKGRWVKA | 621 | Q7Z6J4 | |
| REWLEIDLGEKKKIT | 311 | Q8N8Z6 | |
| GTSDKWEKLEKDILD | 271 | P37059 | |
| LGKIWKLADVDKDGL | 481 | Q9H4M9 | |
| EKELAEAASKWAAEK | 226 | Q8NEY8 | |
| DDTDKLKGKWSSEVL | 36 | Q8IY42 | |
| KDWQAFLDLKKIIDD | 1461 | Q8TE73 | |
| LKVKSEEVFDEWVSK | 126 | Q9H4L5 | |
| EEGVLIDKGKWLLKE | 1736 | P56715 | |
| AWELGKVKGLKLEEL | 311 | Q9GZY0 | |
| WLEKEIEEATKKLGF | 341 | Q9BYC5 | |
| VKGWLKGLEDDKQET | 1626 | Q2WGJ9 | |
| KVDLVLEKEVAGLWI | 81 | P17900 | |
| ETKILLDHEKEWKLG | 561 | P54136 | |
| IWEAIKDFFDAEIKK | 1056 | P07814 | |
| DVGIKLLEWFKIDSL | 456 | Q8TEU7 | |
| IRKKGADVWFKELDI | 46 | P05109 | |
| KWRKEILDEEDFQGL | 451 | Q9NU19 | |
| AKELELLGGWTDDKK | 136 | Q9P0V3 | |
| AIVWLKEHDVKKEDG | 396 | O43776 | |
| LLKDWEKCEKGIADS | 7671 | Q8NF91 | |
| DFKVGWKKLKEVFSI | 241 | Q9P2K5 | |
| IKVKFEDIKDWSDLV | 166 | Q9HC36 | |
| TWIKDDKIKFILEVL | 626 | Q5H9M0 | |
| DEKWGPELDIEKTKL | 1476 | Q96Q15 | |
| EAEKFTCWKKVLLGE | 351 | Q9NVD3 | |
| LAELLGWKKELEDLV | 331 | Q8IXJ6 | |
| RLEEVQFWKKELDDK | 66 | Q969V4 | |
| VKEALEVDWSSEKAK | 216 | Q9UBE0 | |
| FDVDKKKGLTLIELW | 476 | P55809 | |
| VEWYKKGIEELEKGI | 146 | Q9UBP0 | |
| KEKAEIEAKEACDWL | 446 | Q96QB1 | |
| EEEKWAEKAVDALVK | 26 | Q99717 | |
| AELASNKEWLDKIEK | 1321 | Q01082 | |
| KSGAIIEKWRVKLED | 61 | Q67FW5 | |
| AIWEKIEGFVNKLDE | 776 | Q13023 | |
| EKVDSINEKWELLGK | 1036 | Q13023 | |
| QEAEWKEKAIKELEE | 131 | P09496 | |
| EEFWKFKELLKQPLE | 21 | Q7RTR0 | |
| SDLLEKVKWAKENDE | 421 | Q7Z4H8 | |
| HLKKEQEEAWKLEVG | 151 | Q6AZZ1 | |
| KEWVIIDKETELKDF | 541 | Q5TCY1 | |
| FSLEKKTIEWAEEIK | 56 | Q9NZ09 | |
| KTIEWAEEIKKIEEA | 61 | Q9NZ09 | |
| LKEELKAEKKSGFWD | 76 | Q86YL5 | |
| LAANKDWLDKVDKEG | 1326 | O15020 | |
| QVEIEKKWIKIDGED | 711 | Q9Y6Q2 | |
| WLNKEKGIFKIEDSA | 271 | O95238 | |
| EESWIKEKKLLVGSE | 1776 | Q13813 | |
| SLKDLEKEFVDFWEK | 1431 | Q9BX26 | |
| DDFEKLIWEISGGKL | 771 | O75152 | |
| ETWKTIFAKEKGKFE | 721 | P23497 | |
| DLEDWEELEKFSKSK | 736 | Q9H269 | |
| KDKAFELELSWVGEL | 206 | P25788 | |
| TGVELDDVWELQKKF | 1106 | P02549 | |
| PELLTEAEKKEWVEK | 516 | P31939 | |
| EAEKKEWVEKLTEVS | 521 | P31939 | |
| LWLKDVLKEEGVSFL | 1206 | P78527 | |
| KWKEGSFEIVEKENK | 21 | Q86T82 | |
| KDVIVEFTKEEWKLL | 11 | P17030 | |
| VEKSIRDLEGKVKWL | 471 | Q6ZR37 | |
| EIIKVKVKEEDHTWD | 21 | Q6R2W3 | |
| IIWLEGKDVLIDFFK | 866 | Q5TAH2 | |
| FGELVWRIISEKKLK | 566 | Q7Z403 | |
| LADEDWEKKIEGLNF | 1266 | Q9Y4F4 | |
| ADKSVKFWDFELVKD | 516 | Q9UNX4 | |
| LIWKEIKSFLKGSFE | 1301 | O15050 | |
| KEKLEGWLVSIKIAF | 386 | Q9H9Y6 | |
| VTVKWGKEKFEGVEL | 6 | P54578 | |
| DFQLKGIVEEKFVKW | 556 | Q5TAX3 | |
| LKEDIKEFFKISGWE | 46 | Q8N5T2 | |
| ISKKKEELPLWETFV | 2716 | Q6ZQQ6 | |
| IKNEKLEWAVDDEEK | 731 | Q9NYI0 | |
| WPGKDEKEVEFLKIL | 316 | Q8IWR1 | |
| KIQAEEGDKEKWDFL | 476 | Q5FWF4 | |
| KDKTVEEAKVAFLKW | 1986 | Q6PIF6 | |
| WTIEEKELFEQGLAK | 121 | Q5VVJ2 |